尼奥金公司 NEOG
$11.76 +$0.08 (+0.68%)
休市 · Nov 6, 9:50 pm ET · 最新盘后价 $11.76 0.00%
开盘$11.68
昨收$11.68
当日区间$11.45 – $11.99
成交量2.41M
市值$2.57B
市盈率（TTM）–
股息率–
NEOG 相关新闻
匹配 Neogen 或代码 NEOG 的头条新闻，按最新排序。
- Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $14 正面
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)
- William Blair Maintains Neogen(NEOG.US) With Hold Rating
- Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
- Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $13 正面
- Piper Sandler Upgrades Neogen(NEOG.US) to Buy Rating, Raises Target Price to $14 正面
- Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $12
- Analysts Conflicted on These Healthcare Names: Neogen (NEOG), Pfizer (PFE) and Hinge Health, Inc. Class A (HNGE)
- Neogen Q1 Adj. EPS $0.08 Beats $(0.07) Estimate, Sales $222.800M Beat $208.175M Estimate 正面
- Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
- Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
- Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $12 正面
- Neogen | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Ranalli Tamara A.
- Neogen | 3: Initial statement of beneficial ownership of securities-Officer Ranalli Tamara A.
- Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Ranalli Tamara A.
暂无评论——快来第一个聊聊 NEOG。
登录后参与讨论。